COMPLETED

Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this protocol is to begin an exercise program combined with behavioral counseling for patients who are hospitalized with a cystic fibrosis exacerbation. The exercise program will begin during the hospital stay. Beginning an exercise program during this period of reduced mobility and isolation may be an ideal time to deliver a structured exercise prescription along with a behavioral program to promote long-term adherence to exercise (structured physical activity) . Hospitalized patients have an acute awareness that their lung function is declining and may be more motivated and open to changing their behavior and adding exercise to their treatment regimen.

Official Title

Feasibility of a New Model for Exercise Prescription Combined With Behavior Modification in Cystic Fibrosis

Quick Facts

Study Start:2020-12-01
Study Completion:2025-12-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04075864

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Confirmed diagnosis of CF
  2. 2. 18 years old or older
  3. 3. Current pulmonary exacerbation with planned UAB hospitalization for at least 10 days
  4. 4. Willing to participate in a regular, ongoing exercise program
  5. 5. Access to broadband internet
  1. 1. Currently exercising more than 60 min/week
  2. 2. Massive hemoptysis or pneumothorax in past 3 months
  3. 3. Neuromusculoskeletal impairments that preclude exercise

Contacts and Locations

Principal Investigator

Stefanie Krick, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35233
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Stefanie Krick, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-01
Study Completion Date2025-12-10

Study Record Updates

Study Start Date2020-12-01
Study Completion Date2025-12-10

Terms related to this study

Additional Relevant MeSH Terms

  • Cystic Fibrosis